Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Schuhmacher

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Genes, Brain, and Behavior|October 1, 2008
Germline expression of H-Ras(G12V) causes neurological deficits associated to Costello syndromeJ Viosca, A J Schuhmacher, C Guerra, et al.
Oncogene|August 1, 2017
Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomasD Yan, J Kowal, L Akkari, et al.
Plos One|July 28, 2016
Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging GliomasA G de Lucas, A J Schuhmacher, M Oteo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 11, 2019
A spotlight on cancer researchers in Spain: new paradigms and disruptive ideasS Ramón Y Cajal, P Sancho, L Soucek, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Genes, Brain, and Behavior|October 1, 2008
Germline expression of H-Ras(G12V) causes neurological deficits associated to Costello syndromeJ Viosca, A J Schuhmacher, C Guerra, et al.
Oncogene|August 1, 2017
Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomasD Yan, J Kowal, L Akkari, et al.
Plos One|July 28, 2016
Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging GliomasA G de Lucas, A J Schuhmacher, M Oteo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 11, 2019
A spotlight on cancer researchers in Spain: new paradigms and disruptive ideasS Ramón Y Cajal, P Sancho, L Soucek, et al.
Pageof 1